Eva Martínez-Balibrea

6PUBLICATIONS
36CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersSpeciation and extinction
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Dec 26, 2025
Loss-of-function genetic screen unveils synergistic efficacy of PARG inhibition with combined 5-fluorouracil and irinotecan treatment in colorectal cancer.

Cristina Queralt, Cristina Moreta-Moraleda, Marta Costa

|Feb 13, 2025
Multikinase Treatment of Glioblastoma: Evaluating the Rationale for Regorafenib.

Ana Maria Muñoz-Mármol, Bárbara Meléndez, Ainhoa Hernandez

|Nov 27, 2024
Assessing the Prognostic Value of Cytoplasmic and Stromal Caveolin-1 in Early Triple-Negative Breast Cancer Undergoing Neoadjuvant Chemotherapy.

Iris Teruel, Eva Castellà, Sabela Recalde

|Nov 26, 2022
Curcumin: A Novel Way to Improve Quality of Life for Colorectal Cancer Patients?

Laura Layos, Eva Martínez-Balibrea, Vicenç Ruiz de Porras

|Nov 27, 2021
Hypoxia: The Cornerstone of Glioblastoma.

Marta Domènech, Ainhoa Hernández, Andrea Plaja

|Oct 24, 2018
Translational Research Opportunities Regarding Homologous Recombination in Ovarian Cancer.

Margarita Romeo, Juan Carlos Pardo, Anna Martínez-Cardús

Pageof 1